Recombinant SARS-CoV-2 Spike RBD(Lambda/C.37) Protein, Human

Artikelnummer: ABB-RP01492
Artikelname: Recombinant SARS-CoV-2 Spike RBD(Lambda/C.37) Protein, Human
Artikelnummer: ABB-RP01492
Hersteller Artikelnummer: RP01492
Alternativnummer: ABB-RP01492-10UG, ABB-RP01492-50UG, ABB-RP01492-100UG, ABB-RP01492-20UG
Hersteller: ABclonal
Wirt: Human
Kategorie: Proteine/Peptide
Spezies Reaktivität: Virus
Immunogen: Arg319-Phe541(L452Q,F490S)
Alternative Synonym: 2019-nCoV RBD Protein, NCP-CoV RBD Protein, RBD, S glycoprotein Subunit1 RBD Protein, S1-RBD protein, novel coronavirus RBD Protein, sars-cov-2
The spike (S) glycoprotein of coronaviruses contains protrusions that will only bind to certain receptors on the host cell. Known receptors bind S1 are ACE2, angiotensin-converting enzyme 2, DPP4, dipeptidyl peptidase-4, APN, aminopeptidase N, CEACAM, carcinoembryonic antigen-related cell adhesion molecule 1, Sia, sialic acid, O-ac Sia, O-acetylated sialic acid. The spike is essential for both host specificity and viral infectivity. The term peplomer is typically used to refer to a grouping of heterologous proteins on the virus surface that function together. The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Its been reported that SARS-CoV-2 (COVID-19 coronavirus, 2019-nCoV) can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. The main functions for the Spike protein are summarized as: Mediate receptor binding and membrane fusion, Defines the range of the hosts and specificity of the virus, Main component to bind with the neutralizing antibody, Key target for vaccine design, Can be transmitted between different hosts through gene recombination or mutation of the receptor binding domain (RBD), leading to a higher mortality rate.
Konzentration: < 0.1 EU/µg of the protein by LAL method.
Molekulargewicht: 27.70 kDa
NCBI: 43740568
UniProt: P0DTC2
Reinheit: 95 % as determined by SDS-PAGE.
Formulierung: Lyophilized from a 0.22 µm filtered solution of PBS, pH 7.4.
Target-Kategorie: SARS-CoV-2 Spike RBD(Lambda/C.37)
Application Verdünnung: Lyophilized from a 0.22 µm filtered solution of PBS, pH 7.4.
Anwendungsbeschreibung: Cross-Reactivity: Centrifuge the vial before opening. Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. Avoid vortex or vigorously pipetting the protein. For long term storage,it is recommended to add a carrier protein or stablizer (e.g. 0.1% BSA,5% HSA,10% FBS or 5% Trehalose),and aliquot the reconstituted protein solution to minimize free-thaw cycles., ResearchArea: Other Recombinant Protein
Recombinant SARS-CoV-2 Spike RBD(Lambda/C.37) Protein was determined by SDS-PAGE under reducing conditions with Coomassie Blue.
Immobilized SARS-CoV-2 Spike RBD (Lambda/C.37)(Avi) at 2µg/mL (100µL/well) can bind Human ACE2 (Catalog: RP01275) with a linear range of 0.1-6.43 ng/mL.